Gary Goldberg
Principal investigator, leads SENTRIMED, INC..
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$604KFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $604K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Nov 29, 2023 | NIH | STTR Phase I Targeting OSCC cells with a lozenge to treat oral cancer | $248K | SENTRIMED, INC. |
| Jul 14, 2023 | NIH | STTR Phase I Targeting OSCC cells with a lozenge to treat oral cancer | $34K | SENTRIMED, INC. |
| Jul 6, 2022 | NIH | STTR Phase I Targeting OSCC cells with a lozenge to treat oral cancer | $323K | SENTRIMED, INC. |
Peer ranks
Federal funding#2,180
Awards as PI#822
Patents#273
Companies
- SENTRIMED, INC.Leads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.